Detalhe da pesquisa
1.
Coronary flow capacity and survival prediction after revascularization: physiological basis and clinical implications.
Eur Heart J
; 45(3): 181-194, 2024 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37634192
2.
Does financial hardship associate with abnormal quantitative myocardial perfusion and major adverse cardiovascular event?
J Nucl Cardiol
; 30(4): 1528-1539, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36639611
3.
Design and rationale of the randomized trial of comprehensive lifestyle modification, optimal pharmacological treatment and utilizing PET imaging for quantifying and managing stable coronary artery disease (the CENTURY study).
Am Heart J
; 237: 135-146, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33762179
4.
Subendocardial and Transmural Myocardial Ischemia: Clinical Characteristics, Prevalence, and Outcomes With and Without Revascularization.
JACC Cardiovasc Imaging
; 16(1): 78-94, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36599572
5.
Regional, Artery-Specific Thresholds of Quantitative Myocardial Perfusion by PET Associated with Reduced Myocardial Infarction and Death After Revascularization in Stable Coronary Artery Disease.
J Nucl Med
; 60(3): 410-417, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30115688
6.
Combined intense lifestyle and pharmacologic lipid treatment further reduce coronary events and myocardial perfusion abnormalities compared with usual-care cholesterol-lowering drugs in coronary artery disease.
J Am Coll Cardiol
; 41(2): 263-72, 2003 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12535820